PT  - JOURNAL ARTICLE
AU  - Rodrigues, Carina
AU  - Baía, Inês
AU  - Domingues, Rosa
AU  - Barros, Henrique
TI  - Pregnancy and breastfeeding during COVID-19 pandemic: A systematic review of published pregnancy cases
AID  - 10.1101/2020.04.25.20079509
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.25.20079509
4099  - http://medrxiv.org/content/early/2020/04/29/2020.04.25.20079509.short
4100  - http://medrxiv.org/content/early/2020/04/29/2020.04.25.20079509.full
AB  - Background The COVID-19 pandemic is an emerging concern regarding the potential adverse effects during pregnancy. This study reviews knowledge on the impact of COVID-19 on pregnancy and describes the outcome of published cases of pregnant women diagnosed with COVID-19, as well as the characteristics of COVID-19 positive women who delivered in Portugal by 31 of March 2020.Methods Searches were conducted in PubMed® up to 8 April 2020, using PRISMA standards, to identify original published studies describing pregnant women at any gestational age diagnosed COVID-19. There were no date or language restrictions on the search. All identified studies were included irrespective of assumptions on study quality. Portuguese cases were ascertained by contact with all Portuguese maternities and based on the information provided by their health professionals.Results We identified 30 original studies reporting 212 cases of pregnant women with COVID-19 (30 discharged while pregnant), 200 from China and 12 from other countries. The 182 published deliveries resulted in one stillbirth and 185 live births. Four women with severe COVID-19 required admission to an intensive care unit but no cases of maternal death were reported. There was one neonatal death. Preterm births occurred in 28.7% of cases, but it is unclear whether this was iatrogenic. All cases with amniotic fluid, placenta, and/or cord blood analyzed for the SARS-CoV-2 virus were negative. Four newborns were positive for SARS-CoV-2 and three newborns had high levels of IgM antibodies. None of the first eight infants born in Portugal tested positive. Breast milk samples from 13 mothers and described in seven studies showed no evidence of SARS-CoV-2.Conclusion The evidence related to the effect of COVID-19 on pregnant women is still limited. Pregnant women and newborns should be considered particularly vulnerable populations regarding COVID-19 prevention and management strategies.Why was this study conducted?Pregnant women and newborns are exposed to COVID-19 and at risk for adverse outcomes. The review of evidence is essential to guide preventive action and therapy.What are the key findings?Fetal distress and preterm delivery seem to be more frequent among COVID-19 pregnant women. Also, evidence on vertical transmission is emerging but the clinical relevance of the fetal infection remains unclear. No evidence links the SARS-CoV-2 virus to transmission via breast milk.What does this study add to what is already known?The comprehensive review of 212 pregnant women with COVID-19, summarizes the evidence on vertical transmission, as well as adverse maternal and neonatal outcomes. Additionally, it adds the characteristics of the first eight cases of COVID-19 positive women delivered in Portugal.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by national funding from the Foundation for Science and Technology – FCT (Portuguese Ministry of Science, Technology and Higher Education), the Operational Programmes Competitiveness and Internationalization (COMPETE 2020) and Human Capital (POCH), Portugal 2020, under the Unidade de Investigação em Epidemiologia - Instituto Saúde Pública da Universidade do Porto (EPIUnit) (POCI-01-0145-FEDER-006862; UID/DTP/04750/2019) and the PhD grant SFRH/BD/111794/2015 (CR).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a systematic review.